CYP2C19-dependent clopidogrel resistance is a possible cause for coronary stent and peripheral bypass occlusion

Back

ESC Premium Access

CYP2C19-dependent clopidogrel resistance is a possible cause for coronary stent and peripheral bypass occlusion

Session: Poster Session 1 - Antiplatelet and anticoagulant drugs

Topic: Antiplatelet Drugs

Speaker: Assistant Professor M. Klinceva (Skopje, MK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Assistant Professor Milka Klinceva

Zan Mitrev Clinic, Skopje (North Macedonia)

2 presentations

1 follower

5 more presentations in this session

Aspirin resistance in patients with stable coronary heart disease

Speaker: Doctor T. Petroni (Montauban, FR)

Access

Abstract

Fourier-spectroscopy capacity in assessment of resistance to acetylsalicylic acid in patients with stable angina pectoris

Speaker: Mrs A. Kosinova (Krasnoyarsk, RU)

Access

Abstract

Slides

Residual risk following myocardial infarction despite intensive medical management

Speaker: Professor R. Rosenson (New York, US)

Access

Abstract

Slides

Role of rivaroxaban in left ventricular thrombi

Speaker: Doctor A. Almaghraby (Ras Al Khaimah, AE)

Access

Abstract

Slides

Time to event analysis in patients managed on rivaroxaban while taking concurrent interacting medications (CIM)

Speaker: Doctor J. Michel (Austin, US)

Access

Abstract

Slides

Access the full session

Poster Session 1 - Antiplatelet and anticoagulant drugs

Speakers: Assistant Professor M. Klinceva, Doctor T. Petroni, Mrs A. Kosinova, Professor R. Rosenson, Doctor A. Almaghraby...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources